Jennifer L. Breschkin-Mckimm
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference.
Journal: Antiviral research
Published: December 14, 2021
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
Journal: Antiviral research
Published: July 11, 2021
Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors.
Journal: Antiviral research
Published: May 11, 2020
Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
Journal: Antiviral research
Published: April 15, 2019
Influenza Virus Neuraminidase Structure and Functions.
Journal: Frontiers in microbiology
Published: October 25, 2018
Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalk.
Journal: Acta crystallographica. Section F, Structural biology communications
Published: July 16, 2018
Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro- N-acetylneuraminic Acid Derivatives.
Journal: Journal of medicinal chemistry
Published: February 06, 2018
Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.
Journal: Antiviral research
Published: December 18, 2017
Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.
Journal: Antiviral research
Published: November 09, 2017
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
Journal: Antiviral research
Published: January 21, 2016
Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN).
Journal: Antiviral research
Published: July 20, 2015
Last Updated: 09/26/2026